Showing results (21-30 of 305) with videos related to
Sort By:
Pageof 31
Acta Paediatrica (Oslo, Norway : 1992). Supplement|May 25, 2006
The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry diseaseMichael BeckHuman Genetics|November 8, 2006
New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapyMichael BeckWiener Medizinische Wochenschrift (1946)|August 18, 2010
Villa Metabolica - a center of excellence for the diagnosis and treatment of lysosomal storage disordersMichael BeckDevelopmental Medicine and Child Neurology|November 2, 2017
Treatment strategies for lysosomal storage disordersMichael BeckExpert Opinion on Investigational Drugs|May 31, 2002
Agalsidase alfa--a preparation for enzyme replacement therapy in Anderson-Fabry diseaseMichael BeckExpert Opinion on Biological Therapy|February 25, 2009
Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safetyMichael BeckTherapeutics and Clinical Risk Management|October 10, 2009
Alglucosidase alfa: Long term use in the treatment of patients with Pompe diseaseMichael BeckExpert Opinion on Emerging Drugs|June 19, 2010
Emerging drugs for lysosomal storage diseasesMichael BeckHuman Mutation|May 20, 2008
Does proximal myotonic myopathy show anticipation?Bernd Kruse, Doris Wöhrle, Peter Steinbach, et al.Human Molecular Genetics|December 25, 2002
Interaction of alphaPIX (ARHGEF6) with beta-parvin (PARVB) suggests an involvement of alphaPIX in integrin-mediated signalingGeorg Rosenberger, Inka Jantke, Andreas Gal, et al.Pageof 31